Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Joseph Wawrzyniak

    TitlePostdoctoral Scholar
    SchoolUniversity of California, San Diego
    DepartmentPathology
    Address9500 Gilman Drive #0695
    CA La Jolla 92093
    Phone858-822-5629
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Bianchi-Smiraglia A, Bagati A, Fink EE, Moparthy S, Wawrzyniak J, Marvin EK, Battaglia S, Jowdy P, Kolesnikova M, Foley CE, Berman AE, Kozlova NI, Lipchick BC, Paul-Rosner LM, Bshara W, Ackroyd JJ, Shewach DS, Nikiforov MA. Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools. Oncogene. 2016 May 16. PMID: 27181209.
        View in: PubMed
      2. Bianchi-Smiraglia A, Wawrzyniak J, Bagati A, Marvin EK, Ackroyd J, Moparthy S, Bshara W, Fink EE, Foley CE, Morozevich GE, Berman AE, Shewach DS, Nikiforov MA. Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity. Cell Death Differ. 2015 Nov; 22(11):1858-64. PMID: 25909885.
        View in: PubMed
      3. Wawrzyniak J, Bianchi-Smiraglia A, Bshara W, Mannava S, Ackroyd J, Bagati A, Omilian AR, Im M, Fedtsova N, Miecznikowski JC, Moparthy KC, Zucker SN, Zhu Q, Kozlova NI, Berman AE, Hoek KS, Gudkov AV, Shewach DS, Morrison CD, Nikiforov MA. A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion. Cell Rep. 2013 Oct 31; 5(2):493-507. PMID: 24139804.
        View in: PubMed
      4. Mannava S, Moparthy KC, Wheeler LJ, Leonova KI, Wawrzyniak J, Bianchi-Smiraglia A, Berman AE, Flanagan S, Shewach DS, Zeitouni NC, Gudkov AV, Mathews CK, Nikiforov MA. Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion. Aging (Albany NY). 2012 Dec; 4(12):917-22. PMID: 23249808.
        View in: PubMed
      5. Zucker SN, Zirnheld J, Bagati A, DiSanto TM, Des Soye B, Wawrzyniak J, Etemadi K, Nikiforov M, Berezney R. Preferential induction of apoptotic cell death in melanoma cells as compared with normal keratinocytes using a non-thermal plasma torch. Cancer Biol Ther. 2012 Nov; 13(13):1299-306. PMID: 22895073.
        View in: PubMed
      6. Mannava S, Zhuang D, Nair JR, Bansal R, Wawrzyniak J, Zucker SN, Fink EE, Moparthy KC, Hu Q, Liu S, Boise LH, Lee KP, Nikiforov MA. KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells. Blood. 2012 Feb 9; 119(6):1450-8. PMID: 22144178.
        View in: PubMed
      7. Mannava S, Omilian AR, Wawrzyniak J, Fink EE, Zhuang D, Miecznikowski JC, Marshall JR, Soengas MS, Sears RC, Morrison CD, Nikiforov MA. PP2A-B56a controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene. 2012 Mar 22; 31(12):1484-92. PMID: 21822300.
        View in: PubMed
      8. Zhuang D, Mannava S, Grachtchouk V, Tang WH, Patil S, Wawrzyniak J, Berman AE, Giordano TJ, Prochownik EV, Soengas MS, Nikiforov MA. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene. 2008 Nov 6; 27(52):6623-34. PMID: 18679422.
        View in: PubMed